SCHEMBL24908330

SCHEMBL24908330

Bc1c(B)c(B)c2c(-c3cccc(-c4ccccc4)c3)c3c(B)c(B)c(B)c(B)c3c(-c3ccc(-c4ccc5oc6cc7ccccc7cc6c5c4)cc3)c2c1B

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.37
PLA2G4A P47712 4/20 0.37
PLA2G10 O15496 1/20 0.37
PRKDC P78527 3/20 0.36
ANO1 Q5XXA6 1/20 0.34
PGR P06401 1/20 0.34
GAA P10253 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TBK1 Q9UHD2 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ESR1 P03372 2/20 0.32
ESR2 Q92731 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26010882 0.99 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10PRKDCANO1
SCHEMBL26019202 0.96 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10PRKDCANO1
SCHEMBL25684384 0.96 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10PRKDCANO1
SCHEMBL23109602 0.96 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10PRKDCANO1
SCHEMBL21940070 0.95 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10PRKDCPGR
SCHEMBL23109323 0.94 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10PRKDCANO1
SCHEMBL25789710 0.93 HSD17B1 (0.37) PLA2G2APLA2G4APLA2G10ANO1PGR
SCHEMBL29332371 0.91 ESR1 (0.36) PLA2G2APLA2G4AANO1PGRKDM4E
SCHEMBL25785798 0.91 PGR (0.36) PLA2G2APLA2G4APRKDCANO1PGR
SCHEMBL25580827 0.91 PGR (0.36) PLA2G2APLA2G4APRKDCANO1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047477-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-16 US disclosed
US-20230042023-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-09 US disclosed
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230020436-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS MRPS22, RER1, EMC2 PLA2G2A 2426/4885PLA2G4A 3946/4885PLA2G10 2695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.